Skip to content
  • Tuesday, 25 August 2026
  • 1:10 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
Laboratory Automation & Robotics

How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Lana Keisha Jul 23, 2026 0

More than a decade ago, the American Society of Clinical Oncology (ASCO) initiated CancerLinQ, a pioneering platform designed with the…

Read More
Laboratory Automation & Robotics

How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Lana Keisha Jul 16, 2026 0

Over a decade ago, the American Society of Clinical Oncology (ASCO) initiated a groundbreaking endeavor with the launch of CancerLinQ,…

Read More
Laboratory Automation & Robotics

How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Lana Keisha Jul 9, 2026 0

In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…

Read More
CERN Researchers Identify Potential Cracks in the Standard Model Following Unprecedented Observations at the Large Hadron ColliderExplosive Growth and Early Origins of Chronic Myeloid Leukemia Revealed in Landmark Genomic StudyAbacus AI Emerges as a Comprehensive Solution Addressing AI Tool Sprawl and Enhancing Enterprise Workflow AutomationScience News: A Century of Empowering Public Understanding of Science, Medicine, and Technology
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ